Plain-English translation of NCT05424029 on ClinicalTrials.gov ↗ · Source last updated · Translation generated · How we translate trials
Researchers at Memorial Sloan Kettering are studying tiny particles found in fluid from your airways to see if they can help predict whether non-small cell lung cancer might come back after surgery. During your routine lung cancer surgery, doctors will rinse your airways and collect the fluid — this won't add extra time or risk to your procedure. The goal is to understand whether these particles can serve as an early warning sign of recurrence.
Currently, doctors don't have a reliable way to predict which patients are at highest risk for their lung cancer returning after surgery. This research aims to find a simple test using fluid already being removed during your operation that could help identify recurrence risk earlier, when treatment options may be more effective.
You likely qualify if…
You likely don't qualify if…
Your participation is straightforward: during your planned lung cancer surgery, the surgical team will rinse your airways with fluid and collect the sample as part of the study. This happens during your routine procedure and does not extend surgery time or add new risks. You will not need extra visits — the sample collection is integrated into care you're already receiving. After surgery, researchers will analyze the fluid to look for those special particles.
AI-generated summary from trial data · Jul 15, 2026 · Not medical advice
United States